The Bull Rankings scorecard — our quality-growth score is 30.6 / 100, built from three pillars scored 0–100: Quality 17, Growth 100, Value 17 (valuation is judged against sector peers).
The thesis
Quantum Computing Inc. (QUBT) is a growth play that has earned a 30.6/100 quality‑growth score from our model. The score is anchored almost entirely in the Growth pillar, which sits at 100, while Quality lags at 17 and Value at 17. That imbalance tells us the market is pricing in a very high growth trajectory, but it is not yet convinced the business can sustain that pace or that the cash‑flow story will materialise. The price of $9.16 sits well below the analyst consensus 1‑year target of $18.67 and inside the $10–$32 range, yet the model flags a “Diluting shareholders” signal, warning that capital structure could erode value if the company continues to issue equity or take on debt.
Three figures crystallise the case:
- Revenue growth of 82.8 % YoY – a headline that drives the Growth pillar to its maximum.
- Free cash flow of –$51 m – the absence of positive FCF explains why our reverse‑DCF produced no read; the company is still burning cash to build its quantum platform.
- Debt‑to‑equity of 0.01 – an almost negligible leverage profile that keeps the risk of financial distress low, but also limits the ability to fund expansion through debt.
The thesis is simple: QUBT is a high‑growth, low‑leverage company that is still in a cash‑burn phase. If the revenue engine can translate into cash flow within the next 12–18 months, the stock is a compelling bet on the quantum‑hardware revolution.
What the business actually is
QUBT is an integrated photonics company that sells thin‑film lithium niobate chips for optical devices. These chips power electro‑optical modulators, periodically poled devices for frequency conversion, and micro‑ring resonator cavities. The company is also developing two quantum‑centric products: the Entropy Quantum Computer (EQC), a quantum application of its core photonics technology aimed at solving complex optimization problems, and Emucore, a reprogrammable reservoir computing machine optimized for recurrent neural network workloads. The customer base spans commercial and government markets in the United States, with a focus on high‑performance computing and defense applications.
Revenue growth is driven almost entirely by the EQC and Emucore segments, which are still in early deployment but are attracting significant interest from large enterprises and federal agencies. The photonics chip business provides a recurring revenue stream and a platform for future quantum‑hardware expansions.
Why it can (or can't) keep compounding
The moat here is technology ownership. QUBT’s thin‑film lithium niobate platform is a proprietary fabrication process that delivers higher modulation speeds and lower loss than competing silicon‑based photonics. This gives the company a cost advantage that is hard to replicate without substantial R&D investment. Moreover, the EQC and Emucore products are built on the same chip architecture, creating a cross‑sell opportunity that can accelerate adoption across different verticals.
Capital efficiency remains a question. With a debt‑to‑equity of 0.01, the company can fund growth without diluting shareholders, but its free cash flow of –$51 m indicates that the current revenue stream is not yet cash‑positive. The model’s “Diluting shareholders” signal suggests that if the company continues to issue equity to fund research, the share price could be further compressed. However, the high growth rate of 82.8 % YoY is a strong counterweight, implying that the company is on a trajectory to reach breakeven cash flow as the quantum platform matures.
The valuation question
The price already assumes a high growth scenario. Our model’s Growth pillar at 100 reflects the 82.8 % revenue growth, but the Value pillar of 17 places QUBT on the expensive side of its sector peers. The lack of a reverse‑DCF read means we cannot infer an implied growth rate from free cash flow; the market is essentially pricing in the revenue growth without a cash‑flow anchor.
Using the price‑to‑sales (P/S) multiple is the most appropriate valuation metric here, given the absence of earnings. This is higher than the sector average for photonics companies, which typically trade around 3–4x P/S.
In short, the price is already pricing in optimism: it expects the company to keep growing at 80 %+ and to eventually become cash‑positive. If the revenue engine stalls or the quantum products fail to gain traction, the valuation will be over‑stretched.
The bear case
The most compelling skeptic argument is the negative free cash flow of –$51 m. Cash burn is a red flag for a company that is still building its product line. If the company cannot convert its revenue growth into positive cash flow within the next 12–18 months, the dilution risk will materialise, and the high valuation will crumble. A concrete signal that would confirm this scenario is a continued decline in free cash flow or a sharp increase in capital expenditures that outpaces revenue growth.
What would change our mind
- Free cash flow turns positive within the next fiscal year. A shift from –$51 m to a positive figure would validate the growth narrative and remove the dilution concern.
- Revenue growth slows below 50 % YoY. A deceleration would weaken the Growth pillar, pulling the overall score down and making the current valuation less defensible.
- Debt‑to‑equity rises above 0.05. An increase in leverage would erode the low‑risk profile and could trigger the “Diluting shareholders” signal, turning the stock into a riskier play.
If any of these thresholds are crossed, the thesis would need to be revisited. Until then, QUBT remains a high‑growth, high‑valuation bet on the next wave of quantum hardware.